BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9708800)

  • 1. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
    Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
    Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
    Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
    J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
    EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors.
    Saaristo A; Partanen TA; Arola J; Jussila L; Hytönen M; Mäkitie A; Vento S; Kaipainen A; Malmberg H; Alitalo K
    Am J Pathol; 2000 Jul; 157(1):7-14. PubMed ID: 10880369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.
    Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K
    Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoplakin and Plakoglobin--specific markers of lymphatic vessels in the skin?
    Fedele C; Berens D; Rautenfeld V; Pabst R
    Anat Histol Embryol; 2004 Jun; 33(3):168-71. PubMed ID: 15144286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
    Ji RC; Miura M; Qu P; Kato S
    Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
    Wilting J; Papoutsi M; Christ B; Nicolaides KH; von Kaisenberg CS; Borges J; Stark GB; Alitalo K; Tomarev SI; Niemeyer C; Rössler J
    FASEB J; 2002 Aug; 16(10):1271-3. PubMed ID: 12060670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues.
    Partanen TA; Arola J; Saaristo A; Jussila L; Ora A; Miettinen M; Stacker SA; Achen MG; Alitalo K
    FASEB J; 2000 Oct; 14(13):2087-96. PubMed ID: 11023993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
    Valtola R; Salven P; Heikkilä P; Taipale J; Joensuu H; Rehn M; Pihlajaniemi T; Weich H; deWaal R; Alitalo K
    Am J Pathol; 1999 May; 154(5):1381-90. PubMed ID: 10329591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
    Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
    Partanen TA; Alitalo K; Miettinen M
    Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
    Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
    Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
    Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
    White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
    Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
    Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
    Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.